Thrombin (Human) Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 21-Jan-2022
No. of pages: 75

This report contains market size and forecasts of Thrombin (Human) in global, including the following market information:

Global Thrombin (Human) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Thrombin (Human) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Thrombin (Human) companies in 2021 (%)

The global Thrombin (Human) market was valued at 581.3 million in 2021 and is projected to reach US$ 715.7 million by 2028, at a CAGR of 3.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

500IU/Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Thrombin (Human) include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL and Bayer, etc. In 2021,

The global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thrombin (Human) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Thrombin (Human) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Thrombin (Human) Market Segment Percentages, by Type, 2021 (%)

- 500IU/Vial

- 1000IU/Vial

- 2500IU/Vial

Global Thrombin (Human) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Thrombin (Human) Market Segment Percentages, by Application, 2021 (%)

- Biotechnology

- Medicine

- Microbiology

- Others

Global Thrombin (Human) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Thrombin (Human) Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thrombin (Human) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Thrombin (Human) revenues share in global market, 2021 (%)

Key companies Thrombin (Human) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Thrombin (Human) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Baxter

- AMRESCO Inc

- BD Biosciences

- Life Technologies Corporation

- PromoCell GmbH

- Sigma-Aldrich Corporation

- Vitrolife AB

- CSL

- Bayer

- Grifols

- Octapharma

- Shanghai RAAS

- Hualan Biological

Thrombin (Human) Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Thrombin (Human) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thrombin (Human) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thrombin (Human) Overall Market Size
2.1 Global Thrombin (Human) Market Size: 2021 VS 2028
2.2 Global Thrombin (Human) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Thrombin (Human) Sales: 2017-2028
3 Company Landscape
3.1 Top Thrombin (Human) Players in Global Market
3.2 Top Global Thrombin (Human) Companies Ranked by Revenue
3.3 Global Thrombin (Human) Revenue by Companies
3.4 Global Thrombin (Human) Sales by Companies
3.5 Global Thrombin (Human) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Thrombin (Human) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Thrombin (Human) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Thrombin (Human) Players in Global Market
3.8.1 List of Global Tier 1 Thrombin (Human) Companies
3.8.2 List of Global Tier 2 and Tier 3 Thrombin (Human) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Thrombin (Human) Market Size Markets, 2021 & 2028
4.1.2 500IU/Vial
4.1.3 1000IU/Vial
4.1.4 2500IU/Vial
4.2 By Type - Global Thrombin (Human) Revenue & Forecasts
4.2.1 By Type - Global Thrombin (Human) Revenue, 2017-2022
4.2.2 By Type - Global Thrombin (Human) Revenue, 2023-2028
4.2.3 By Type - Global Thrombin (Human) Revenue Market Share, 2017-2028
4.3 By Type - Global Thrombin (Human) Sales & Forecasts
4.3.1 By Type - Global Thrombin (Human) Sales, 2017-2022
4.3.2 By Type - Global Thrombin (Human) Sales, 2023-2028
4.3.3 By Type - Global Thrombin (Human) Sales Market Share, 2017-2028
4.4 By Type - Global Thrombin (Human) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Thrombin (Human) Market Size, 2021 & 2028
5.1.2 Biotechnology
5.1.3 Medicine
5.1.4 Microbiology
5.1.5 Others
5.2 By Application - Global Thrombin (Human) Revenue & Forecasts
5.2.1 By Application - Global Thrombin (Human) Revenue, 2017-2022
5.2.2 By Application - Global Thrombin (Human) Revenue, 2023-2028
5.2.3 By Application - Global Thrombin (Human) Revenue Market Share, 2017-2028
5.3 By Application - Global Thrombin (Human) Sales & Forecasts
5.3.1 By Application - Global Thrombin (Human) Sales, 2017-2022
5.3.2 By Application - Global Thrombin (Human) Sales, 2023-2028
5.3.3 By Application - Global Thrombin (Human) Sales Market Share, 2017-2028
5.4 By Application - Global Thrombin (Human) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Thrombin (Human) Market Size, 2021 & 2028
6.2 By Region - Global Thrombin (Human) Revenue & Forecasts
6.2.1 By Region - Global Thrombin (Human) Revenue, 2017-2022
6.2.2 By Region - Global Thrombin (Human) Revenue, 2023-2028
6.2.3 By Region - Global Thrombin (Human) Revenue Market Share, 2017-2028
6.3 By Region - Global Thrombin (Human) Sales & Forecasts
6.3.1 By Region - Global Thrombin (Human) Sales, 2017-2022
6.3.2 By Region - Global Thrombin (Human) Sales, 2023-2028
6.3.3 By Region - Global Thrombin (Human) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Thrombin (Human) Revenue, 2017-2028
6.4.2 By Country - North America Thrombin (Human) Sales, 2017-2028
6.4.3 US Thrombin (Human) Market Size, 2017-2028
6.4.4 Canada Thrombin (Human) Market Size, 2017-2028
6.4.5 Mexico Thrombin (Human) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Thrombin (Human) Revenue, 2017-2028
6.5.2 By Country - Europe Thrombin (Human) Sales, 2017-2028
6.5.3 Germany Thrombin (Human) Market Size, 2017-2028
6.5.4 France Thrombin (Human) Market Size, 2017-2028
6.5.5 U.K. Thrombin (Human) Market Size, 2017-2028
6.5.6 Italy Thrombin (Human) Market Size, 2017-2028
6.5.7 Russia Thrombin (Human) Market Size, 2017-2028
6.5.8 Nordic Countries Thrombin (Human) Market Size, 2017-2028
6.5.9 Benelux Thrombin (Human) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Thrombin (Human) Revenue, 2017-2028
6.6.2 By Region - Asia Thrombin (Human) Sales, 2017-2028
6.6.3 China Thrombin (Human) Market Size, 2017-2028
6.6.4 Japan Thrombin (Human) Market Size, 2017-2028
6.6.5 South Korea Thrombin (Human) Market Size, 2017-2028
6.6.6 Southeast Asia Thrombin (Human) Market Size, 2017-2028
6.6.7 India Thrombin (Human) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Thrombin (Human) Revenue, 2017-2028
6.7.2 By Country - South America Thrombin (Human) Sales, 2017-2028
6.7.3 Brazil Thrombin (Human) Market Size, 2017-2028
6.7.4 Argentina Thrombin (Human) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Thrombin (Human) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Thrombin (Human) Sales, 2017-2028
6.8.3 Turkey Thrombin (Human) Market Size, 2017-2028
6.8.4 Israel Thrombin (Human) Market Size, 2017-2028
6.8.5 Saudi Arabia Thrombin (Human) Market Size, 2017-2028
6.8.6 UAE Thrombin (Human) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Baxter
7.1.1 Baxter Corporate Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Thrombin (Human) Major Product Offerings
7.1.4 Baxter Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.1.5 Baxter Key News
7.2 AMRESCO Inc
7.2.1 AMRESCO Inc Corporate Summary
7.2.2 AMRESCO Inc Business Overview
7.2.3 AMRESCO Inc Thrombin (Human) Major Product Offerings
7.2.4 AMRESCO Inc Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.2.5 AMRESCO Inc Key News
7.3 BD Biosciences
7.3.1 BD Biosciences Corporate Summary
7.3.2 BD Biosciences Business Overview
7.3.3 BD Biosciences Thrombin (Human) Major Product Offerings
7.3.4 BD Biosciences Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.3.5 BD Biosciences Key News
7.4 Life Technologies Corporation
7.4.1 Life Technologies Corporation Corporate Summary
7.4.2 Life Technologies Corporation Business Overview
7.4.3 Life Technologies Corporation Thrombin (Human) Major Product Offerings
7.4.4 Life Technologies Corporation Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.4.5 Life Technologies Corporation Key News
7.5 PromoCell GmbH
7.5.1 PromoCell GmbH Corporate Summary
7.5.2 PromoCell GmbH Business Overview
7.5.3 PromoCell GmbH Thrombin (Human) Major Product Offerings
7.5.4 PromoCell GmbH Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.5.5 PromoCell GmbH Key News
7.6 Sigma-Aldrich Corporation
7.6.1 Sigma-Aldrich Corporation Corporate Summary
7.6.2 Sigma-Aldrich Corporation Business Overview
7.6.3 Sigma-Aldrich Corporation Thrombin (Human) Major Product Offerings
7.6.4 Sigma-Aldrich Corporation Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.6.5 Sigma-Aldrich Corporation Key News
7.7 Vitrolife AB
7.7.1 Vitrolife AB Corporate Summary
7.7.2 Vitrolife AB Business Overview
7.7.3 Vitrolife AB Thrombin (Human) Major Product Offerings
7.7.4 Vitrolife AB Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.7.5 Vitrolife AB Key News
7.8 CSL
7.8.1 CSL Corporate Summary
7.8.2 CSL Business Overview
7.8.3 CSL Thrombin (Human) Major Product Offerings
7.8.4 CSL Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.8.5 CSL Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Thrombin (Human) Major Product Offerings
7.9.4 Bayer Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.9.5 Bayer Key News
7.10 Grifols
7.10.1 Grifols Corporate Summary
7.10.2 Grifols Business Overview
7.10.3 Grifols Thrombin (Human) Major Product Offerings
7.10.4 Grifols Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.10.5 Grifols Key News
7.11 Octapharma
7.11.1 Octapharma Corporate Summary
7.11.2 Octapharma Thrombin (Human) Business Overview
7.11.3 Octapharma Thrombin (Human) Major Product Offerings
7.11.4 Octapharma Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.11.5 Octapharma Key News
7.12 Shanghai RAAS
7.12.1 Shanghai RAAS Corporate Summary
7.12.2 Shanghai RAAS Thrombin (Human) Business Overview
7.12.3 Shanghai RAAS Thrombin (Human) Major Product Offerings
7.12.4 Shanghai RAAS Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.12.5 Shanghai RAAS Key News
7.13 Hualan Biological
7.13.1 Hualan Biological Corporate Summary
7.13.2 Hualan Biological Thrombin (Human) Business Overview
7.13.3 Hualan Biological Thrombin (Human) Major Product Offerings
7.13.4 Hualan Biological Thrombin (Human) Sales and Revenue in Global (2017-2022)
7.13.5 Hualan Biological Key News
8 Global Thrombin (Human) Production Capacity, Analysis
8.1 Global Thrombin (Human) Production Capacity, 2017-2028
8.2 Thrombin (Human) Production Capacity of Key Manufacturers in Global Market
8.3 Global Thrombin (Human) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Thrombin (Human) Supply Chain Analysis
10.1 Thrombin (Human) Industry Value Chain
10.2 Thrombin (Human) Upstream Market
10.3 Thrombin (Human) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Thrombin (Human) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Thrombin (Human) in Global Market
Table 2. Top Thrombin (Human) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Thrombin (Human) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Thrombin (Human) Revenue Share by Companies, 2017-2022
Table 5. Global Thrombin (Human) Sales by Companies, (K Units), 2017-2022
Table 6. Global Thrombin (Human) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Thrombin (Human) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Thrombin (Human) Product Type
Table 9. List of Global Tier 1 Thrombin (Human) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thrombin (Human) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Thrombin (Human) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Thrombin (Human) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Thrombin (Human) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Thrombin (Human) Sales (K Units), 2017-2022
Table 15. By Type - Global Thrombin (Human) Sales (K Units), 2023-2028
Table 16. By Application - Global Thrombin (Human) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Thrombin (Human) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Thrombin (Human) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Thrombin (Human) Sales (K Units), 2017-2022
Table 20. By Application - Global Thrombin (Human) Sales (K Units), 2023-2028
Table 21. By Region - Global Thrombin (Human) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Thrombin (Human) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Thrombin (Human) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Thrombin (Human) Sales (K Units), 2017-2022
Table 25. By Region - Global Thrombin (Human) Sales (K Units), 2023-2028
Table 26. By Country - North America Thrombin (Human) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Thrombin (Human) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Thrombin (Human) Sales, (K Units), 2017-2022
Table 29. By Country - North America Thrombin (Human) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Thrombin (Human) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Thrombin (Human) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Thrombin (Human) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Thrombin (Human) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Thrombin (Human) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Thrombin (Human) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Thrombin (Human) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Thrombin (Human) Sales, (K Units), 2023-2028
Table 38. By Country - South America Thrombin (Human) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Thrombin (Human) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Thrombin (Human) Sales, (K Units), 2017-2022
Table 41. By Country - South America Thrombin (Human) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Thrombin (Human) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Thrombin (Human) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Thrombin (Human) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Thrombin (Human) Sales, (K Units), 2023-2028
Table 46. Baxter Corporate Summary
Table 47. Baxter Thrombin (Human) Product Offerings
Table 48. Baxter Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. AMRESCO Inc Corporate Summary
Table 50. AMRESCO Inc Thrombin (Human) Product Offerings
Table 51. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. BD Biosciences Corporate Summary
Table 53. BD Biosciences Thrombin (Human) Product Offerings
Table 54. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Life Technologies Corporation Corporate Summary
Table 56. Life Technologies Corporation Thrombin (Human) Product Offerings
Table 57. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. PromoCell GmbH Corporate Summary
Table 59. PromoCell GmbH Thrombin (Human) Product Offerings
Table 60. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Sigma-Aldrich Corporation Corporate Summary
Table 62. Sigma-Aldrich Corporation Thrombin (Human) Product Offerings
Table 63. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Vitrolife AB Corporate Summary
Table 65. Vitrolife AB Thrombin (Human) Product Offerings
Table 66. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. CSL Corporate Summary
Table 68. CSL Thrombin (Human) Product Offerings
Table 69. CSL Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bayer Corporate Summary
Table 71. Bayer Thrombin (Human) Product Offerings
Table 72. Bayer Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Grifols Corporate Summary
Table 74. Grifols Thrombin (Human) Product Offerings
Table 75. Grifols Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Octapharma Corporate Summary
Table 77. Octapharma Thrombin (Human) Product Offerings
Table 78. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Shanghai RAAS Corporate Summary
Table 80. Shanghai RAAS Thrombin (Human) Product Offerings
Table 81. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Hualan Biological Corporate Summary
Table 83. Hualan Biological Thrombin (Human) Product Offerings
Table 84. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Thrombin (Human) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Thrombin (Human) Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Thrombin (Human) Production by Region, 2017-2022 (K Units)
Table 88. Global Thrombin (Human) Production by Region, 2023-2028 (K Units)
Table 89. Thrombin (Human) Market Opportunities & Trends in Global Market
Table 90. Thrombin (Human) Market Drivers in Global Market
Table 91. Thrombin (Human) Market Restraints in Global Market
Table 92. Thrombin (Human) Raw Materials
Table 93. Thrombin (Human) Raw Materials Suppliers in Global Market
Table 94. Typical Thrombin (Human) Downstream
Table 95. Thrombin (Human) Downstream Clients in Global Market
Table 96. Thrombin (Human) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Thrombin (Human) Segment by Type
Figure 2. Thrombin (Human) Segment by Application
Figure 3. Global Thrombin (Human) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Thrombin (Human) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Thrombin (Human) Revenue, 2017-2028 (US$, Mn)
Figure 7. Thrombin (Human) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Thrombin (Human) Revenue in 2021
Figure 9. By Type - Global Thrombin (Human) Sales Market Share, 2017-2028
Figure 10. By Type - Global Thrombin (Human) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Thrombin (Human) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Thrombin (Human) Sales Market Share, 2017-2028
Figure 13. By Application - Global Thrombin (Human) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Thrombin (Human) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Thrombin (Human) Sales Market Share, 2017-2028
Figure 16. By Region - Global Thrombin (Human) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Thrombin (Human) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Thrombin (Human) Sales Market Share, 2017-2028
Figure 19. US Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Thrombin (Human) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Thrombin (Human) Sales Market Share, 2017-2028
Figure 24. Germany Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 25. France Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Thrombin (Human) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Thrombin (Human) Sales Market Share, 2017-2028
Figure 33. China Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 37. India Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Thrombin (Human) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Thrombin (Human) Sales Market Share, 2017-2028
Figure 40. Brazil Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Thrombin (Human) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Thrombin (Human) Sales Market Share, 2017-2028
Figure 44. Turkey Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Thrombin (Human) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Thrombin (Human) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Thrombin (Human) by Region, 2021 VS 2028
Figure 50. Thrombin (Human) Industry Value Chain
Figure 51. Marketing Channels
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs